Deadly proposal: A case of catecholaminergic polymorphic ventricular tachycardia

Pediatric Emergency Care

Volumn 27, Issue 11, 2011, Pages 1065-1068

  Heiner, Jason D ^a   Bullard Berent, Jeffrey H ^b,c   Inbar, Shmuel ^c  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b Mary Bridge Children's Hospital   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

catecholaminergic polymorphic ventricular tachycardia; clinical genetics; CPVT; sudden death; ventricular tachycardia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADOLESCENT; ARTICLE; AUTOMATED EXTERNAL DEFIBRILLATOR; BRUGADA SYNDROME; CARDIOPULMONARY ARREST; CASE REPORT; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CLINICAL FEATURE; DANCING; DEFIBRILLATOR; EMOTION; EXERCISE TEST; FAMILY; FOLLOW UP; GENETIC SCREENING; HEART RHYTHM; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE BIGEMINY; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MALE; RARE DISEASE; RESUSCITATION; SHORT QT SYNDROME; SUDDEN DEATH; UNCONSCIOUSNESS;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; CARDIOPULMONARY RESUSCITATION; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DEFIBRILLATORS; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EXERCISE TEST; FAMILY HEALTH; FEMALE; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HEART ARREST; HETEROZYGOTE; HUMANS; HYPOTHERMIA, INDUCED; MALE; MUTATION, MISSENSE; POINT MUTATION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; STRESS, PSYCHOLOGICAL; SYNCOPE; TACHYCARDIA, VENTRICULAR; VENTRICULAR PREMATURE COMPLEXES;

EID: 80955123683     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0b013e3182360606     Document Type: Article

References (36)

1. Lewis DA, Dhala A. Syncope in the pediatric patient. The cardiologist's perspective. Pediatr Clin North Am. 1999;46:205-219.
2. Driscoll DJ, Jacobsen SJ, Porter CJ, et al. Syncope in children and adolescents. J Am Coll Cardiol. 1997;29:1039-1045. (Pubitemid 27149579)
3. Massin MM, Bourguignont A, Coremans C, et al. Syncope in pediatric patients presenting to an emergency department. J Pediatr. 2004;145:223-228. (Pubitemid 38993396)
4. Reid DS, Tynan M, Braidwood L, et al. Bidirectional tachycardia in a child. A study using His bundle electrography. Br Heart J. 1975;37:339-344.
5. Coumel P, Fidelle J, Lucet V, et al. Catecholamine-induced severe ventricular arrhythmias with Adam-Stokes syndrome in children: Report of four cases. Br Heart J. 1978;40(suppl):28-37.
6. Leenhardt A, Lucet V, Denjoy I, et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512-1519.
7. Celiker A, Erdǒan I, Karagöz T, et al. Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia. Cardiol Young. 2009;19:45-52.
8. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69-74. (Pubitemid 34747444)
9. Laitinen PJ, Brown KM, Piippo K, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation. 2001;103:485-490. (Pubitemid 32116230)
10. Priori SG, Napolitano C, Grillo M. Concealed arrhythmogenic syndromes: The hidden substrate of idiopathic ventricular fibrillation? Cardiovasc Res. 2001;50:218-223.
11. Lahat H, Pras E, Olender T, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet. 2001;69:1378-1384. (Pubitemid 33124218)
12. Liu N, Colombi B, Memmi M, et al. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: Insights from a RyR2 R4496C knock-in mouse model. Circ Res. 2006;99:292-298. (Pubitemid 44174937)
13. Song L, Alcalai R, Arad M, et al. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Invest. 2007;117:1814-1823. (Pubitemid 47036315)
14. Mohamed U, Napolitano C, Priori SG. Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol. 2007;18:791-797. (Pubitemid 46934514)
15. Napolitano C, Priori SG, Bloise R. Catecholaminergic polymorphic ventricular tachycardia. In: Pagon RA, Bird TC, Dolan CR, et al, eds. GeneReviews [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2004, [updated July 7, 2009].
16. Postma AV, Denjoy I, Kamblock J, et al. Catecholaminergic polymorphic ventricular tachycardia: RyR2 mutations, bradycardia, and follow up of the patients. J Med Genet. 2005;42:863-870. (Pubitemid 41598196)
17. Krahn AD, Gollob M, -ee R, et al. Diagnosis of unexplained cardiac arrest: Role of adrenaline and procainamide infusion. Circulation. 2005;112:2228-2234. (Pubitemid 41464564)
18. Tester DJ, Ackerman MJ. Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children. Annu Rev Med. 2009;60:69-84.
19. Maron MS. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy. J Cardiovasc Transl Res. 2009;2:415-425.
20. Kiés P, Bootsma M, Bax J, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Screening, diagnosis, and treatment. Heart Rhythm. 2006;3:225-234.
21. Chiang CE, Roden DM. The long QT syndromes: Genetic basis and clinical implications. J Am Coll Cardiol. 2000;36:1-12. (Pubitemid 30466104)
22. Kaufman ES. Mechanisms and clinical management of inherited channelopathies: Long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Heart Rhythm. 2009;6(suppl 8):S51-S55.
23. Gussak I, Brugada P, Brugada J, et al. Idiopathic short QT interval: A new clinical syndrome? Cardiology. 2000;94:99-102.
24. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: Report of the second consensus conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111:659-670.
25. Rossenbacker T, Priori SG. The Brugada syndrome. Curr Opin Cardiol. 2007;22:163-170. (Pubitemid 46581191)
26. Mark DG, Brady WJ, Pines JM. Preexcitation syndromes: Diagnostic consideration in the ED. Am J Emerg Med. 2009;27:878-888.
27. Katz G, Arad M, Eldar M. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond. Curr Probl Cardiol. 2009;34:9-43.
28. Hayashi M, Denjoy I, Extramiana F, et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation. 2009;119:2426-2434.
29. Johnson JN, Tester DJ, Bass NE, et al. Cardiac channel molecular autopsy for sudden unexpected death in epilepsy. J Child Neurol. 2010;25:916-921.
30. Tester DJ, Spoon DB, Valdivia HH, et al. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: A molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin Proc. 2004;79:1380-1384.
31. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117;e350-e408. (Pubitemid 351771339)
32. Wilde AA, Bhuiyan ZA, Crotti L, et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med. 2008;358:2024-2029. (Pubitemid 351656456)
33. Larsen MP, Eisenberg MS, Cummins RO, et al. Predicting survival from out-of-hospital cardiac arrest: A graphic model. Ann Emerg Med. 1993;22:1652-1658. (Pubitemid 23319830)
34. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 4: The automated external defibrillator: Key link in the chain of survival. The American Heart Association in Collaboration with the International Liaison Committee on Resuscitation. Circulation. 2000;102(suppl 8):I60YI76.
35. Lotfi K, White L, Rea T, et al. Cardiac arrest in schools. Circulation. 2007;116:1374-1379. (Pubitemid 47417563)
36. Drezner JA, Rao AL, Heistand J, et al. Effectiveness of emergency response planning for sudden cardiac arrest in United States high schools with automated external defibrillators. Circulation. 2009;120:518-525.